Overview
SCIENTIFIC SCORE
Possibly Effective
Based on 51 Researches
7.9
USERS' SCORE
Good
Based on 29 Reviews
8.4
Supplement Facts
Serving Size: 2 Capsules
Amount Per Serving
%DV
Total Carbohydrate
<1g
<1%†
Calcium (from calcium magnesium phytate)
131 mg
10%
Phosphorus (from calcium magnesium phytate)
192 mg
15%
Magnesium (from calcium magnesium phytate)
40 mg
10%
IP-6 (inositol hexaphosphate) (from calcium magnesium phytate)
800 mg
**
Inositol
220 mg
**
Maitake Mushroom Extract standardized to 30% pure D-fraction (9 mg)
30 mg
**
Cat's Claw Extract (bark) standardized to 4% alkaloids (0.4 mg)
10 mg
**
Top Medical Research Studies
9
IP6 shows promise against prostate cancer
We explored how inositol hexaphosphate (IP6), a natural compound, influences prostate cancer growth and development in a mouse model. Male TRAMP mice were given either regular water or a solution with 2% IP6 for 8-15 weeks, starting at different ages. Remarkably, IP6 treatment halted tumor growth at earlier stages and significantly reduced the incidence of aggressive cancer types by 55-70%.
Additionally, IP6 appears to target cancer stem cells, which play a role in tumor persistence and progression. In lab tests, IP6 reduced self-renewal in cancer stem cell clusters by about 90%. Overall, our findings highlight IP6's potential as a powerful tool in early-stage prostate cancer prevention.
Additionally, IP6 appears to target cancer stem cells, which play a role in tumor persistence and progression. In lab tests, IP6 reduced self-renewal in cancer stem cell clusters by about 90%. Overall, our findings highlight IP6's potential as a powerful tool in early-stage prostate cancer prevention.
Read More
9
We investigated the potential benefits of Myo-inositol, a naturally occurring sugar alcohol, on DU-145 prostate cancer cells. By treating these cancer cells with various doses of Myo-inositol, we determined its half-maximal inhibitory concentration (IC50) using a simple method that measures cell viability.
Our findings revealed that Myo-inositol significantly decreased the viability of DU-145 cells, showing an IC50 of 0.06 mg/ml. This suggests that Myo-inositol may effectively inhibit cancer cell growth.
Furthermore, we performed a detailed proteomic analysis using advanced techniques to explore how Myo-inositol changes protein expression. We found notable differences in protein levels between treated and untreated cells, particularly in areas linked to key cellular functions like cytoskeletal regulation, apoptosis (cell death), and stress responses. For instance, certain proteins tied to tumor suppression were upregulated in response to Myo-inositol treatment.
Overall, these observations highlight Myo-inositol's potential as a therapeutic option. However, further studies are necessary to unravel the underlying mechanisms and assess its effectiveness in combination with other treatments for managing prostate cancer, especially castration-resistant prostate cancer (CRPC).
Our findings revealed that Myo-inositol significantly decreased the viability of DU-145 cells, showing an IC50 of 0.06 mg/ml. This suggests that Myo-inositol may effectively inhibit cancer cell growth.
Furthermore, we performed a detailed proteomic analysis using advanced techniques to explore how Myo-inositol changes protein expression. We found notable differences in protein levels between treated and untreated cells, particularly in areas linked to key cellular functions like cytoskeletal regulation, apoptosis (cell death), and stress responses. For instance, certain proteins tied to tumor suppression were upregulated in response to Myo-inositol treatment.
Overall, these observations highlight Myo-inositol's potential as a therapeutic option. However, further studies are necessary to unravel the underlying mechanisms and assess its effectiveness in combination with other treatments for managing prostate cancer, especially castration-resistant prostate cancer (CRPC).
Read More
9
We investigated how isogarcinol (ISO) influences breast cancer cells and what mechanisms are at play. Through lab tests, we found that ISO at 13 μM effectively lowered cell growth and movement. In living subjects, doses of 5 to 15 mg/kg showed a significant reduction in tumor activity.
We observed that ISO achieves its tumor-suppressing effects by lowering the levels of a protein called methionyl-tRNA synthetase (MARS) and deactivating key pathways involved in cancer progression. These findings suggest ISO could be a valuable addition to breast cancer treatment strategies.
We observed that ISO achieves its tumor-suppressing effects by lowering the levels of a protein called methionyl-tRNA synthetase (MARS) and deactivating key pathways involved in cancer progression. These findings suggest ISO could be a valuable addition to breast cancer treatment strategies.
Read More
Most Useful Reviews
9
Remission success
85 people found this helpful
READ THIS—MAX3 HELPS KILL GLIOBLASTOMA BRAIN CANCER. This product has put my Mum in remission from glioblastoma brain cancer! With MAX3, MSM, Frankincense pills, and black seed oil, her MRIs have been clear! This cancer was deemed a death sentence, yet here she is happily wearing her beautiful wigs. I have been advised to make her "eat" this all day. Her immune system is functioning exceptionally well and combating cancer. I firmly believe this product, among others, has kept her healthy and alive. While she is undergoing chemotherapy and radiation treatments, she occasionally feels a bit "run down".
Read More
9
Dog survival
42 people found this helpful
We give this to our dog, who had cancer and was advised for hospice by the vet. The foster mum believed she might thrive with this supplement. After six months, she's doing remarkably well—happy and active, showing no signs of the disease returning.
Read More
10
Cancer free
40 people found this helpful
This is an extraordinary product; my sister had Stage 3 ovarian cancer and is now cancer-free after using it. My cousin had a lump in her chest that also disappeared thanks to this product.
Read More
Medical Researches
SCIENTIFIC SCORE
Possibly Effective
Based on 51 Researches
7.9
- All Researches
9.5
We examined the potential of a specific β-glucan, GFPBW1, derived from maitake mushrooms to enhance the effectiveness of cancer vaccines. The study involved the use of OVA-antigen and a B16-OVA tumor model to see how GFPBW1 might improve immune responses.
Our findings indicated that different doses of GFPBW1 significantly boosted the activation and maturation of immune cells known as antigen presenting cells (APCs). By increasing important markers, we observed greater immune responses, which included higher levels of OVA-specific antibody subtypes like IgG1 and IgG3. This suggests that GFPBW1 could effectively work as an adjuvant, facilitating both Th1 (cell-mediated) and Th2 (humoral) immune responses, which are crucial in fighting cancer.
Additionally, we noted that when GFPBW1 was combined with aluminum, commonly used in vaccines, it led to even higher levels of specific antibodies, creating a balanced immune response. Importantly, the mice that received GFPBW1 with the vaccine did not show any harmful side effects.
In tumor models, GFPBW1 demonstrated remarkable potential in suppressing tumors when used in preventive settings and also enhanced the effects of therapeutic vaccines. The research highlighted a significant increase in targeting immune cells directly to the tumor environment, which illustrates the beneficial role GFPBW1 could play in both vaccine development and cancer therapy.
Our findings indicated that different doses of GFPBW1 significantly boosted the activation and maturation of immune cells known as antigen presenting cells (APCs). By increasing important markers, we observed greater immune responses, which included higher levels of OVA-specific antibody subtypes like IgG1 and IgG3. This suggests that GFPBW1 could effectively work as an adjuvant, facilitating both Th1 (cell-mediated) and Th2 (humoral) immune responses, which are crucial in fighting cancer.
Additionally, we noted that when GFPBW1 was combined with aluminum, commonly used in vaccines, it led to even higher levels of specific antibodies, creating a balanced immune response. Importantly, the mice that received GFPBW1 with the vaccine did not show any harmful side effects.
In tumor models, GFPBW1 demonstrated remarkable potential in suppressing tumors when used in preventive settings and also enhanced the effects of therapeutic vaccines. The research highlighted a significant increase in targeting immune cells directly to the tumor environment, which illustrates the beneficial role GFPBW1 could play in both vaccine development and cancer therapy.
Read More
9
We explored how inositol hexaphosphate (IP6) can combat chemotherapy resistance in colorectal cancer, particularly after oxaliplatin treatment. Using advanced models, we found that prolonged stress on cancer cells leads to resistance, primarily due to cellular senescence.
Through our research, we confirmed that IP6 effectively reversed this resistance by targeting specific cellular pathways. By interfering with PERK activation and diphthamide modification, IP6 showed great promise in enhancing chemotherapy effectiveness. Overall, our findings highlight IP6's potential as a valuable addition to cancer treatment regimens.
Through our research, we confirmed that IP6 effectively reversed this resistance by targeting specific cellular pathways. By interfering with PERK activation and diphthamide modification, IP6 showed great promise in enhancing chemotherapy effectiveness. Overall, our findings highlight IP6's potential as a valuable addition to cancer treatment regimens.
Read More
9
We explored a novel treatment for pulmonary metastatic breast cancer using degradable capsules filled with DNA enzymes. These capsules, made from a special material and designed to release their contents in acidic environments, showed promising results in lab experiments.
The DNA enzymes successfully targeted cancer cells, leading to the reduction of harmful proteins and promoting cell death in tumors. Our findings suggest this approach could be an effective strategy for attacking both primary and metastatic breast cancer.
Overall, the study indicates a step forward in gene therapy for tough cancer cases.
The DNA enzymes successfully targeted cancer cells, leading to the reduction of harmful proteins and promoting cell death in tumors. Our findings suggest this approach could be an effective strategy for attacking both primary and metastatic breast cancer.
Overall, the study indicates a step forward in gene therapy for tough cancer cases.
Read More
9
IP6 shows promise against prostate cancer
We explored how inositol hexaphosphate (IP6), a natural compound, influences prostate cancer growth and development in a mouse model. Male TRAMP mice were given either regular water or a solution with 2% IP6 for 8-15 weeks, starting at different ages. Remarkably, IP6 treatment halted tumor growth at earlier stages and significantly reduced the incidence of aggressive cancer types by 55-70%.
Additionally, IP6 appears to target cancer stem cells, which play a role in tumor persistence and progression. In lab tests, IP6 reduced self-renewal in cancer stem cell clusters by about 90%. Overall, our findings highlight IP6's potential as a powerful tool in early-stage prostate cancer prevention.
Additionally, IP6 appears to target cancer stem cells, which play a role in tumor persistence and progression. In lab tests, IP6 reduced self-renewal in cancer stem cell clusters by about 90%. Overall, our findings highlight IP6's potential as a powerful tool in early-stage prostate cancer prevention.
Read More
9
Biodegradable nanoparticles enhance cancer therapy
We examined a promising new treatment for cancer that involves biodegradable nanoparticles made with inositol hexaphosphate (IP6). These nanoparticles effectively release copper ions that enhance the production of hydroxyl radicals, which are crucial for combating tumors.
Notably, this new agent outperforms traditional methods by degrading in response to glutathione levels, thereby improving cancer treatment efficiency. Our findings suggest that this innovative approach could pave the way for more effective, guided cancer therapies.
Notably, this new agent outperforms traditional methods by degrading in response to glutathione levels, thereby improving cancer treatment efficiency. Our findings suggest that this innovative approach could pave the way for more effective, guided cancer therapies.
Read More
User Reviews
USERS' SCORE
Good
Based on 29 Reviews
8.4
- All Reviews
- Positive Reviews
- Negative Reviews
9
Remission success
85 people found this helpful
READ THIS—MAX3 HELPS KILL GLIOBLASTOMA BRAIN CANCER. This product has put my Mum in remission from glioblastoma brain cancer! With MAX3, MSM, Frankincense pills, and black seed oil, her MRIs have been clear! This cancer was deemed a death sentence, yet here she is happily wearing her beautiful wigs. I have been advised to make her "eat" this all day. Her immune system is functioning exceptionally well and combating cancer. I firmly believe this product, among others, has kept her healthy and alive. While she is undergoing chemotherapy and radiation treatments, she occasionally feels a bit "run down".
Read More
9
Dog survival
42 people found this helpful
We give this to our dog, who had cancer and was advised for hospice by the vet. The foster mum believed she might thrive with this supplement. After six months, she's doing remarkably well—happy and active, showing no signs of the disease returning.
Read More
10
Cancer free
40 people found this helpful
This is an extraordinary product; my sister had Stage 3 ovarian cancer and is now cancer-free after using it. My cousin had a lump in her chest that also disappeared thanks to this product.
Read More
7.5
Remarkable recovery
23 people found this helpful
Good stuff. Last July, my small dog, aged 9, was diagnosed with lung cancer, given just four months to live without treatment. Following chemotherapy, which nearly proved fatal, there was little improvement, and the cancer seemed to have spread. After I began giving her piroxicam and found this product at the health food store, I noticed a significant improvement within a couple of months. Over 10 months later, my dog is thriving and exhibits only mild gagging in the morning. We no longer see the point in having further x-rays. Unfortunately, Whole Foods stopped carrying the preferred brand, and I ordered a different version online, which I feel is less effective.
Read More
9
Highly recommended
18 people found this helpful
This product is fantastic. It has greatly helped both my mother and me. I would highly recommend it to anyone battling cancer.
Read More
Frequently Asked Questions
7.5
Effective for animals
17 people found this helpful
Cell Forte Max3 has worked wonders for animals with cancer. I’ve seen it help my hedgehog with liver cancer and a friend’s horse with skin cancer. It also aided my dog with autoimmune issues. After one month, a fatty tumour I had shrank by half. This product is exceedingly safe, and I’ve been a fan since 1990.
9
Supports cancer treatment
7 people found this helpful
Since being diagnosed with throat cancer and starting chemotherapy, I've taken Cell Forte MAX3 for a few months. I feel it has helped keep me fighting fit during this challenging time. The quality appears good, and it complements a balanced diet.
7.5
Increases energy
3 people found this helpful
I purchased this for a dog diagnosed with cancer. After starting the supplement, he seems more energetic and less tired. I will continue to give it to him.
7.5
Supports immune system
13 people found this helpful
As a cancer survivor, I've been using Cell Forte Max3 for years to support my immune system. When sick colleagues are around, I take maximum capsules and rarely catch colds or the flu. My friends and family also use it for immune defence.
7.5
Improves dog health
13 people found this helpful
My dog has cancer, and these products have greatly improved his well-being. N-tense and Lactoferrin are also beneficial.
7.5
Noticed benefits
6 people found this helpful
I find this a good product as part of my cancer treatment regime. I notice benefits.
7.5
Fighting cancer
8 people found this helpful
I was advised to give this to my 9-year-old dog diagnosed with hemangiosarcoma. He takes four pills morning and evening, which help his cells combat cancer. I believe they will assist my boy in battling the disease.
References
- Mei W, Yao S, Cai X, Xu Q, Hu H, et al. A multifunctional metal-based nanozyme for CT/PTI-guided photothermal/starvation/chemodynamic therapy against colon tumor. J Mater Chem B. 2025;13:1781. doi:10.1039/d4tb02578d
- Xu B, Jia Q, Liao X, Fan T, Mou L, et al. Inositol hexaphosphate enhances chemotherapy by reversing senescence induced by persistently activated PERK and diphthamide modification of eEF2. Cancer Lett. 2024;582:216591. doi:10.1016/j.canlet.2023.216591
- Jiang R, Li L, Li M. Biomimetic Construction of Degradable DNAzyme-Loaded Nanocapsules for Self-Sufficient Gene Therapy of Pulmonary Metastatic Breast Cancer. ACS Nano. 2023;17:22129. doi:10.1021/acsnano.3c09581
- Mishra N, Pal S, Sharma M, Nisha R, Raj Pal R, et al. Crosslinked and PEGylated Pectin Chitosan nanoparticles for delivery of Phytic acid to colon. Int J Pharm. 2023;639:122937. doi:10.1016/j.ijpharm.2023.122937
- Altaher AM, Adris MA, Aliwaini SH, Awadallah AM, Morjan RY. The Anticancer Effects of Novel Imidazo[1,2-a]Pyridine Compounds against HCC1937 Breast Cancer Cells. Asian Pac J Cancer Prev. 2022;23:2943. doi:10.31557/APJCP.2022.23.9.2943
- Lan TT, Song Y, Liu XH, Liu CP, Zhao HC, et al. IP6 reduces colorectal cancer metastasis by mediating the interaction of gut microbiota with host genes. Front Nutr. 2022;9:979135. doi:10.3389/fnut.2022.979135
- Raina K, Kandhari K, Jain AK, Ravichandran K, Maroni P, et al. Stage-Specific Effect of Inositol Hexaphosphate on Cancer Stem Cell Pool during Growth and Progression of Prostate Tumorigenesis in TRAMP Model. Cancers (Basel). 2022;14. doi:10.3390/cancers14174204
- Liu H, Jiang R, Lu Y, Shan B, Wen Y, et al. Biodegradable Amorphous Copper Iron Tellurite Promoting the Utilization of Fenton-Like Ions for Efficient Synergistic Cancer Theranostics. ACS Appl Mater Interfaces. 2022;14:28537. doi:10.1021/acsami.2c03975
- Liao X, Zhang Y, Xu B, Ali A, Liu X, et al. Inositol hexaphosphate sensitizes hepatocellular carcinoma to oxaliplatin relating inhibition of CCN2-LRP6-β-catenin-ABCG1 signaling pathway. J Cancer. 2021;12:6071. doi:10.7150/jca.62141
- Amabile MI, De Luca A, Tripodi D, D'Alberti E, Melcarne R, et al. Effects of Inositol Hexaphosphate and Myo-Inositol Administration in Breast Cancer Patients during Adjuvant Chemotherapy. J Pers Med. 2021;11. doi:10.3390/jpm11080756
- Badodi S, Pomella N, Zhang X, Rosser G, Whittingham J, et al. Inositol treatment inhibits medulloblastoma through suppression of epigenetic-driven metabolic adaptation. Nat Commun. 2021;12:2148. doi:10.1038/s41467-021-22379-7
- Sandström J, Balian A, Lockowandt R, Fornander T, Nordenskjöld B, et al. IP6K2 predicts favorable clinical outcome of primary breast cancer. Mol Clin Oncol. 2021;14:94. doi:10.3892/mco.2021.2256
- Vucenik I, Druzijanic A, Druzijanic N. Inositol Hexaphosphate (IP6) and Colon Cancer: From Concepts and First Experiments to Clinical Application. Molecules. 2020;25. doi:10.3390/molecules25245931
- Yang J, Eresen A, Shangguan J, Ma Q, Zhang Z, et al. Effect of route of administration on the efficacy of dendritic cell vaccine in PDAC mice. Am J Cancer Res. 2020;10:3911.
- Li C, Ci Y, Liu X, Chen C, Liu C, et al. Inositol Hexakisphosphate and Inositol Enhance the Inhibition of Colorectal Cancer Growth and Liver Metastasis by Capecitabine in a Mouse Model. Nutr Cancer. 2021;73:2306. doi:10.1080/01635581.2020.1820055
- Liu X, Liu C, Chen C, Sun W, Ci Y, et al. Combination of Inositol Hexaphosphate and Inositol Inhibits Liver Metastasis of Colorectal Cancer in Mice Through the Wnt/β-Catenin Pathway. Onco Targets Ther. 2020;13:3223. doi:10.2147/OTT.S247646
- Islam MJ, Muntaha S, Masum MM, Nowshin S, Salam S, et al. Proteomic Analysis of Anticancer Effect of Myo-inositol in Human Prostate Cancer (DU-145) Cell Line. Asian Pac J Cancer Prev. 2024;25:4447. doi:10.31557/APJCP.2024.25.12.4447
- Wen XY, Cao MM, Zhang ZY, Xie N, Wei ZY, et al. [The role of endoplasmic reticulum IP(3)R calcium channel in vitamin E succinate induced autophagy of human gastric cancer cell]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2025;43:180. doi:10.3760/cma.j.cn121094-20240125-00037
- Zhang D, Chu Y, Li M, Du L. Isogarcinol Reduces MARS Levels and Deactivates the PI3K/AKT Pathway to Suppress the Malignant Properties of Breast Cancer Cells. Cell Biochem Biophys. 2025. doi:10.1007/s12013-025-01727-0
- Pan T, Huang J. Polysaccharide with anticancer activity from Grifola frondosa cultured in industrial wastewater of Agaricus bisporus. Int J Biol Macromol. 2024;283:137489. doi:10.1016/j.ijbiomac.2024.137489
- Xu Y, Huang C, Xu T, Xiang X, Amakye WK, et al. A Water Polysaccharide-Protein Complex from Grifola frondosa Inhibit the Growth of Subcutaneous but Not Peritoneal Colon Tumor under Fasting Condition. Mol Nutr Food Res. 2024;68:e2400023. doi:10.1002/mnfr.202400023
- He X, Lu JL, Liao WF, Long YR, Zhang X, et al. GFPBW1, a β-glucan from Grifola frondosa as vaccine adjuvant: APCs activation and maturation. Acta Pharmacol Sin. 2024;45:2394. doi:10.1038/s41401-024-01330-8
- Masuda Y, Yamashita S, Nakayama Y, Shimizu R, Konishi M. Maitake Beta-Glucan Enhances the Therapeutic Effect of Trastuzumab via Antibody-Dependent Cellular Cytotoxicity and Complement-Dependent Cytotoxicity. Biol Pharm Bull. 2024;47:840. doi:10.1248/bpb.b23-00802
- Abosharaf HA, Gebreel DT, Allam S, El-Atrash A, Tousson E. Ehrlich ascites carcinoma provokes renal toxicity and DNA injury in mice: Therapeutic impact of chitosan and maitake nanoparticles. Basic Clin Pharmacol Toxicol. 2024;134:472. doi:10.1111/bcpt.13988
- Li X, Ruan Q, Yang W, Tian H, Wu N, et al. Polysaccharide isolated from eliminates myeloid-derived suppressor cells and inhibits tumor growth by enhancing T cells responses. Int J Biol Sci. 2024;20:664. doi:10.7150/ijbs.85276
- Zhao J, He R, Zhong H, Liu S, Liu X, et al. A cold-water extracted polysaccharide-protein complex from Grifola frondosa exhibited anti-tumor activity via TLR4-NF-κB signaling activation and gut microbiota modification in H22 tumor-bearing mice. Int J Biol Macromol. 2023;239:124291. doi:10.1016/j.ijbiomac.2023.124291
- Abdellaoui M, Kadi A, Abrazi Y, Kadi Y, Gary A, et al. Oral Intake of Combined Natural Immunostimulants Suppresses the 7,12-DMBA/ Croton Oil Induced Two-step Skin Carcinogenesis in Swiss Albino Mice. Gulf J Oncolog. 2023;1:32.
- Masuda Y, Nakayama Y, Shimizu R, Naito K, Miyamoto E, et al. Maitake α-glucan promotes differentiation of monocytic myeloid-derived suppressor cells into M1 macrophages. Life Sci. 2023;317:121453. doi:10.1016/j.lfs.2023.121453
- Zhang H, Dong X, Ji H, Yu J, Liu A. Preparation and structural characterization of acid-extracted polysaccharide from Grifola frondosa and antitumor activity on S180 tumor-bearing mice. Int J Biol Macromol. 2023;234:123302. doi:10.1016/j.ijbiomac.2023.123302
- Aguilera-Braico DM, Balogh GA. CD3Ɛ immune restorative ability induced by Maitake Pro4x in immunosupressed BALBc mice. BMC Res Notes. 2022;15:307. doi:10.1186/s13104-022-06201-1
- Hu Q, Xie B. Effect of Maitake D-fraction in advanced laryngeal and pharyngeal cancers during concurrent chemoradiotherapy: A randomized clinical trial. Acta Biochim Pol. 2022;69:625. doi:10.18388/abp.2020_5996
- Zhao F, Guo Z, Ma ZR, Ma LL, Zhao J. Antitumor activities of Grifola frondosa (Maitake) polysaccharide: A meta-analysis based on preclinical evidence and quality assessment. J Ethnopharmacol. 2021;280:114395. doi:10.1016/j.jep.2021.114395
- Liu C, Ji HY, Wu P, Yu J, Liu AJ. The preparation of a cold-water soluble polysaccharide from Grifola frondosa and its inhibitory effects on MKN-45 cells. Glycoconj J. 2020;37:413. doi:10.1007/s10719-020-09932-0
- Masuda Y, Nakayama Y, Mukae T, Tanaka A, Naito K, et al. Maturation of dendritic cells by maitake α-glucan enhances anti-cancer effect of dendritic cell vaccination. Int Immunopharmacol. 2019;67:408. doi:10.1016/j.intimp.2018.12.039
- Alonso EN, Ferronato MJ, Fermento ME, Gandini NA, Romero AL, et al. Antitumoral and antimetastatic activity of Maitake D-Fraction in triple-negative breast cancer cells. Oncotarget. 2018;9:23396. doi:10.18632/oncotarget.25174
- Roberts KE, Adsett IT, Rickett K, Conroy SM, Chatfield MD, et al. Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer. Cochrane Database Syst Rev. 2022;1:CD013167. doi:10.1002/14651858.CD013167.pub2
- Zari A, Alfarteesh H, Buckner C, Lafrenie R. Treatment with Promotes Apoptosis in B16-BL6 Mouse Melanoma Cells and Inhibits the Growth of B16-BL6 Tumours. Molecules. 2021;26. doi:10.3390/molecules26041066
- Ribeiro AF, Santos JF, Mattos RR, Barros EGO, Nasciutti LE, et al. Characterization and in vitro antitumor activity of polymeric nanoparticles loaded with Uncaria tomentosa extract. An Acad Bras Cienc. 2020;92:e20190336. doi:10.1590/0001-3765202020190336
- Ciani F, Tafuri S, Troiano A, Cimmino A, Fioretto BS, et al. Anti-proliferative and pro-apoptotic effects of Uncaria tomentosa aqueous extract in squamous carcinoma cells. J Ethnopharmacol. 2018;211:285. doi:10.1016/j.jep.2017.09.031
- Kośmider A, Czepielewska E, Kuraś M, Gulewicz K, Pietrzak W, et al. Uncaria tomentosa Leaves Decoction Modulates Differently ROS Production in Cancer and Normal Cells, and Effects Cisplatin Cytotoxicity. Molecules. 2017;22. doi:10.3390/molecules22040620
- Santos KF, Gutierres JM, Pillat MM, Rissi VB, Santos Araújo MD, et al. Uncaria tomentosa extract alters the catabolism of adenine nucleotides and expression of ecto-5'-nucleotidase/CD73 and P2X7 and A1 receptors in the MDA-MB-231 cell line. J Ethnopharmacol. 2016;194:108. doi:10.1016/j.jep.2016.08.051
- Kaiser S, Carvalho ÂR, Pittol V, Dietrich F, Manica F, et al. Genotoxicity and cytotoxicity of oxindole alkaloids from Uncaria tomentosa (cat's claw): Chemotype relevance. J Ethnopharmacol. 2016;189:90. doi:10.1016/j.jep.2016.05.026
- Núñez C, Lozada-Requena I, Ysmodes T, Zegarra D, Saldaña F, et al. [Immunomodulation of Uncaria tomentosa over dendritic cells, il-12 and profile TH1/TH2/TH17 in breast cancer]. Rev Peru Med Exp Salud Publica. 2015;32:643.
- de Paula LC, Fonseca F, Perazzo F, Cruz FM, Cubero D, et al. Uncaria tomentosa (cat's claw) improves quality of life in patients with advanced solid tumors. J Altern Complement Med. 2015;21:22. doi:10.1089/acm.2014.0127
- Deiab S, Mazzio E, Messeha S, Mack N, Soliman KF. High-Throughput Screening to Identify Plant Derived Human LDH-A Inhibitors. European J Med Plants. 2013;3:603.
- Kaiser S, Dietrich F, de Resende PE, Verza SG, Moraes RC, et al. Cat's claw oxindole alkaloid isomerization induced by cell incubation and cytotoxic activity against T24 and RT4 human bladder cancer cell lines. Planta Med. 2013;79:1413. doi:10.1055/s-0033-1350742
- Dreifuss AA, Bastos-Pereira AL, Fabossi IA, Lívero FA, Stolf AM, et al. Uncaria tomentosa exerts extensive anti-neoplastic effects against the Walker-256 tumour by modulating oxidative stress and not by alkaloid activity. PLoS One. 2013;8:e54618. doi:10.1371/journal.pone.0054618
- Farias I, do Carmo Araújo M, Zimmermann ES, Dalmora SL, Benedetti AL, et al. Uncaria tomentosa stimulates the proliferation of myeloid progenitor cells. J Ethnopharmacol. 2011;137:856. doi:10.1016/j.jep.2011.07.011
- Gurrola-Díaz CM, García-López PM, Gulewicz K, Pilarski R, Dihlmann S. Inhibitory mechanisms of two Uncaria tomentosa extracts affecting the Wnt-signaling pathway. Phytomedicine. 2011;18:683. doi:10.1016/j.phymed.2010.11.002
- Pilarski R, Filip B, Wietrzyk J, Kuraś M, Gulewicz K. Anticancer activity of the Uncaria tomentosa (Willd.) DC. preparations with different oxindole alkaloid composition. Phytomedicine. 2010;17:1133. doi:10.1016/j.phymed.2010.04.013
- Dreifuss AA, Bastos-Pereira AL, Avila TV, Soley Bda S, Rivero AJ, et al. Antitumoral and antioxidant effects of a hydroalcoholic extract of cat's claw (Uncaria tomentosa) (Willd. Ex Roem. & Schult) in an in vivo carcinosarcoma model. J Ethnopharmacol. 2010;130:127. doi:10.1016/j.jep.2010.04.029
